Latest Gross Margins News

Rhythm Biosciences has moved ColoSTAT and geneType into commercial use, recording its first sales during FY2026. But with sales revenue of just $85,339, a $5.93 million loss and an auditor-flagged going-concern uncertainty, the next phase will be judged on cash generation and repeat adoption.

Kogan.com (ASX:KGN) crossed $1 billion in annual gross sales as stronger margins, cash generation and a Mighty Ape reset lifted FY26 results. The group returned to statutory profit, ended debt-free and declared another fully franked dividend.

TradeWindow is targeting 13% to 18% revenue growth in FY27 and expects to approach EBITDA breakeven, while preparing to shift its primary listing from the NZX to the ASX. The freight software company also reported rising recurring revenue, stronger customer economics and NZ$4.0 million in cash at 30 June 2026.

SciDev Limited (ASX:SDV) finished FY26 with a sharp annual earnings decline, but a leaner business and stronger second-half performance offer a potential reset. Revenue fell 17% and underlying EBITDA dropped 49%, while the company exited loss-making international operations and rebuilt net cash to $6.8 million.

The Hydration Pharmaceuticals Company (ASX:HPC) has sharply reduced its operating losses, with Hydralyte LLC recording its first monthly EBITDA profit in August. The group remains loss-making overall, but improved margins and a lower cost base are beginning to show in the numbers.

Temple & Webster delivered record FY26 revenue of $664.6 million and lifted underlying EBITDA by 28%, despite a sharp fall in statutory profit after tax. The online retailer is targeting EBITDA of $33 million to $40 million in FY27 as improved margins, exclusive products and adjacent categories do more of the heavy lifting.

SRJ Technologies has secured a US$1.234 million purchase order for an LNG controls upgrade supporting a Middle Eastern National Oil Company. The award adds revenue across FY26 and FY27 while giving SRJ a less site-dependent route to build its Gulf credentials.

Hallenstein Glasson delivered a sharp lift in FY2026 profit as sales, margins and Australian trading strengthened. The NZX-listed retailer also raised its full-year dividend to 69 cents per share, while warning that early FY2027 sales growth is unlikely to persist at the same pace.

Spacetalk Limited (ASX:SPA) has posted a sharply deeper FY26 loss and negative net assets, while its auditor flagged a material uncertainty over the company’s ability to continue as a going concern. The company says a $10 million post-year-end placement, note conversions and new telco agreements give its software-led strategy room to execute.

Zimplats delivered a sharp FY2026 earnings rebound, with revenue up 57% and profit after tax rising to US$276.7 million. The result was driven mainly by stronger PGM prices, while lower sales volumes, higher unit costs, no dividend and rising sulphur dioxide emissions temper the celebration.

Felix Group Holdings has secured A$5.54 million in institutional funding and launched a further A$1 million shareholder purchase plan as it pivots towards an open procurement platform. The ASX-listed software company is also guiding to at least 15% revenue growth in FY27.

Bremworth has restored internal yarn production, cut costs and improved its inventory profile, but FY26 still ended with an NZ$11.4 million loss. The company now enters FY27 under new ownership and board dynamics, with positive operating cash flow still to be achieved.